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STUDY PROTOCOL Open Access
Implementation of family psychosocial risk
assessment in pediatric cancer with the
Psychosocial Assessment Tool (PAT): study
protocol for a cluster-randomized
comparative effectiveness trial
Anne E. Kazak1,2* , Janet A. Deatrick3, Michele A. Scialla4, Eric Sandler5, Rebecca E. Madden6 and Lamia P. Barakat6,7
Abstract
Background: Childhood cancer affects and is affected by multiple levels of the social ecology, including social and
relational determinants of health (e.g., economic stability, housing, childcare, healthcare access, child and family
problems). The 2015 Standards of Psychosocial Care in Pediatric Cancer outline optimal psychosocial care sensitive
to these ecological factors, starting with assessment of psychosocial healthcare needs to promote medical and
psychosocial outcomes across all children with cancer. To address the first standard of family psychosocial
assessment, the Psychosocial Assessment Tool (PAT) is a validated screener ready for broad implementation.
Method: The PAT will be implemented across a national sample of 18 pediatric cancer programs ranging in size
(annual new patients) in a mixed methods, comparative effectiveness study, guided by the Interactive Systems
Framework for Dissemination and Implementation, comparing two implementation strategies. It is hypothesized
that implementation will be more successful at the patient/family, provider, and institutional level when training
(strategy I) is combined with implementation expanded resources (strategy II). There are three aims: (1) Refine the
two implementation strategies using semi-structured qualitative interviews with 19 stakeholders including parent
advocates, providers, pediatric oncology organization representatives, healthcare industry leaders; (2) Compare the
two theoretically based and empirically informed strategies to implement the PAT in English and Spanish using a
cluster-randomized controlled trial across 18 sites. Stratified by size, sites will be randomized to cohort (3) and
strategy (2). Outcomes include adoption and penetration of screening (patient/family), staff job satisfaction/burnout
(provider), and cost-effective use of resources consistent with family risk (institution); (3) Based on the results of the
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trial and feedback from the first and second aim, we will develop and disseminate a web-based PAT
Implementation Toolkit.
Discussion: Use of the PAT across children’s cancer programs nationally can achieve the assessment standard and
inform equitable delivery of psychosocial care matched to family need for all patients.
Trial Registration: ClinicalTrials.gov, NCT04446728, registered 23 June 2020
Keywords: Pediatric cancer, Families, Psychosocial, Risk, Screening, Implementation
Background
The diagnosis and treatment of pediatric cancer affects
and is affected by multiple levels of the social ecology,
including patient and caregiver physical and psycho-
social health. Particularly at risk are families with limited
instrumental (i.e., financial) and social resources and
pre-existing child and family problems. Institute of
Medicine Reports [1, 2] and the Standards of Psycho-
social Care in Pediatric Cancer [3] call for improvement
in delivery of psychosocial care. The standards outline
evidence-based care for all patients and families to im-
prove health, increase access to care, and reduce health
disparities by decreasing distress, addressing risks, and
improving quality of life. The first standard is “youth
with cancer and their family members should routinely
receive systematic assessment of their psychosocial
healthcare needs” [4]. Universal screening at diagnosis
fosters early identification of psychosocial risks and pro-
vides the opportunity to match psychosocial care to the
level of family need for more equitable, effective, and
integrated services. Confirming this, in qualitative inter-
views with multidisciplinary healthcare providers regard-
ing the implementation of screening, the overarching
theme was that screening all families is important be-
cause it facilitates clinical care and partnerships that can
improve outcomes especially for those at risk for dispar-
ities. However, few programs offer such care in an
efficient, comprehensive, consistent manner [5, 6],
highlighting critical gaps in care that can magnify health
disparities.
This study addresses this critical gap in the delivery of
care to our diverse population of children with cancer
and their families by evaluating two approaches to
implementing an evidence-based, parent report screener
of family psychosocial risk in English and Spanish—the
Psychosocial Assessment Tool (PAT) [7, 8]. Risk screen-
ing initiates a process of preventive interventions across
cancer treatment and facilitates access to evidence-based
psychosocial care for children, potentially preventing in-
creased distress and long-term limitations to health-
related quality of life [9, 10]. Universal, systematic
screening assures that assessments are integrated and re-
sources meet the needs of all children with cancer and
their families. However, barriers to universal, systematic
screening and linked evidence-based care have been
identified. The Preparing to Implement the Psychosocial
Standards–Current Staffing and Services (PIPS-CSS)
study of 144 US pediatric cancer programs conducted to
prepare for broad implementation of the standards [5,
11] found that there are challenges and inconsistent in-
terpretations of psychosocial care [5, 11]. Similarly, data
from the Children’s Oncology Group (COG) [6] and a
national survey of social workers [12] demonstrated in-
consistent and often inadequate services. Barriers to im-
plementation are evident, and providers note the
importance of training in terms of how screening is ac-
complished [13].
The Psychosocial Assessment Tool (PAT)
The Psychosocial Assessment Tool (PAT) [7, 8] is an
evidence-based parent/caregiver report screener of fam-
ily psychosocial risk in English and Spanish. The PAT
generates a total score and 7 subscales (family structure,
social support, child problems, sibling problems, family
problems, stress reactions, family beliefs). Since the ini-
tial versions of the PAT [14–16], we have refined the
PAT with the current all literacy version reflecting the
broad assessment of family psychosocial risks. Screening
with the PAT can be completed at diagnosis [17], can be
used by multidisciplinary staff, and facilitates the delivery
of psychosocial care [18]. Embedded in social ecology
theory, the PAT total score maps on to the Psychosocial
Preventative Health Model (PPPHM, Fig. 1) [19], a
three-tier model which represents the distribution of
psychosocial risks across the population of families.
Most families experience some distress but have min-
imal risk factors (low levels of distress, few prior child,
Contributions to the literature
 First study to apply dissemination and implementation
methods to psychosocial screening in pediatric populations,
specifically children with cancer and their families
 Application of rigorous implementation methods to pediatric
health care setting
 Test of implementation of psychosocial screening to reduce
health disparities
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or family problems) and resources (financial resources,
strong social support) that help them cope and adapt to
their child’s illness (universal). A smaller group of fam-
ilies (targeted) have identified areas of risk and moderate
resources. At the top of the pyramid are families with
more severe problems, many risk factors, and few re-
sources (clinical).
Empirical evidence supports the readiness of the PAT
for broad implementation. It is used in 28.9% of
pediatric cancer programs in the USA [11] and widely in
other countries [20–28]. The PAT is acceptable to fam-
ilies across race, ethnicity, and SES [7, 8, 10, 16, 17, 29]
and has been shown to impact psychosocial outcomes at
higher levels of distress when results are shared with
staff [30]. We adapted the PAT for hematopoietic stem
cell transplantation (HCST) [31] including development
of a clinical pathway to facilitate its integration in clin-
ical care [32, 33], and in sickle cell disease, adding items
to capture relevant aspects of the social context for fam-
ilies (e.g., school absences, changes in housing) [34].
We do not know the extent to which the PAT has
been adopted, whether implementation is consistent
across families, and if PAT implementation is sustained.
The best practices for implementation have not been
studied, and barriers and facilitators to systematic imple-
mentation have not been evaluated. Challenges such as
time, determining who will screen, technical difficulties,
and linking screening to care were potential barriers. In
a pilot of an implementation model using a workshop
and consultation calls in three states, 9 of 12 centers
successfully implemented the web-based PAT, half using
both the English and Spanish versions [35]. The pilot
data informs the implementation and measurement
strategies in this study.
Specific aims
Based on the Interactive Systems Framework for Dis-
semination and Implementation (ISF) [36], there are
three stages in this mixed methods research (Fig. 2).
First, two implementation strategies [37], to improve in-
tegration of the PAT into standard pediatric cancer care,
will be refined using feedback from 19 stakeholders
(qualitative methods). The strategies are based on prior
PAT studies, the dissemination and implementation lit-
erature [37], and Social Ecological [38] and Pediatric
Psychosocial Preventative Health Models [19]. Strategy I
is training (webinar) to educate providers on the PAT
and its administration. Strategy II is Training + Imple-
mentation Expanded Resources (TIER), which augments
training with consultation calls and identification of a
site champion. Second, we will conduct a comparative
effectiveness trial of the two strategies at 18 childhood
cancer centers of three sizes examining family (penetra-
tion, health equity), provider (feasibility, acceptability,
Fig. 1 Pediatric Psychosocial Preventative Health Model
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burnout, and job satisfaction), and institution (adoption,
sustainability, costs) implementation outcomes [39]. We
will randomize sites to time of implementation (three
cohorts) and strategy (two—I, II). Third, we will develop
and disseminate a web-based PAT Implementation
Toolkit for family psychosocial risk screening in
pediatric cancer.
Aim 1
Refine strategies I (training) and II (TIER) using semi-
structured interviews with stakeholders—parent advo-
cates, multidisciplinary health care providers, national
pediatric oncology professional organizations, and health
care industry leaders (implementation team).
Aim 2
Compare the two theoretically based and empirically in-
formed strategies to implement the PAT in English and
Spanish using a cluster-randomized controlled trial.
Compared to training:
H2.1. At the patient/family level, TIER will be associ-
ated with: (a) a higher proportion of families of newly di-
agnosed children screened and provided with feedback
(penetration) and (b) higher rates of screening for ethnic
minority and socioeconomically diverse families (health
equity).
H2.2. At the provider level, TIER will be (a) more feas-
ible and rated as appropriate and acceptable, (b) associ-
ated with greater engagement in addressing health
disparities, and (c) associated with less burnout and bet-
ter job satisfaction.
H2.3. At the institution level, TIER will be associated
with: (a) a higher rate of site participation (adoption), (b)
more positive perceptions of implementation benefits
and fewer challenges (sustainability), and (c) psycho-
social care better matched to need demonstrating a
more equitable distribution of services and costs of care.
Aim 3
Based on the results of the trial and further guidance
from the implementation team, we will integrate accept-
able, feasible, and effective strategies to develop and dis-
seminate a web-based PAT Implementation Toolkit.
Methods and design
Overview of the study
The aim of this mixed methods research is to implement
universal, systematic family psychosocial risk screening
with the PAT in English and Spanish to assure that all
families of children newly diagnosed with cancer at the
participating cancer centers are screened. The setting/
context of the research is pediatric cancer programs in
Fig. 2 Interactive systems framework and stages of the implementation study
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the USA. The approach, reflected in the three aims, is
guided by the ISF [36]. We selected specific implementa-
tion strategies from the Expert Recommendations for
Implementing Change (ERIC) project [37] targeting im-
plementation outcomes at three levels (patient/family,
provider, institution). ERIC strategies utilized are noted
in parentheses throughout this article.
Aim 1 corresponds to the first component of the ISF,
Prevention Synthesis and Translation System. We will
prepare programs to implement the PAT by conducting
qualitative semi-structured interviews with a diverse set
of stakeholders (n = 19). Interviews will be focused on
details of strategy I (training via webinar) and strategy II
(training + TIER—consultation calls and identification of
a champion), followed by questions about facilitators
and barriers, and about implementation strategies and
resources needed for universal screening and care deliv-
ery to address health inequities. We anticipate fine-
tuning and adding components to improve penetration
and health equity targets, acceptability and feasibility,
adoption, and sustainability.
The activities of aim 2 correspond to the second com-
ponent of the ISF, Prevention Support System. Support
for those implementing innovation occurs at multiple
levels within the system—patients/families, providers,
and institution. To implement the PAT in English and
Spanish, 18 pediatric cancer programs, of varying sizes
and with geographic distribution assuring representation
of ethnic and racial minority families and families at so-
cioeconomic risk, have agreed to participate. We will
conduct a cluster-randomized comparative effectiveness
trial of the two implementation strategies across three
cohorts stratified by size of site based on new patients
per year (Fig. 3).
Aim 3 activities correspond to the third component of
the ISF, Prevention Delivery System, in the development
and dissemination of the PAT Implementation Toolkit.
Stakeholder interviews to refine implementation
strategies (aim 1)
Qualitative interviews will be conducted with a national
group of diverse stakeholders, selected using purposive
criterion-based sampling [40] to represent different
levels of the social ecology. The data from the interviews
will inform components of the two implementation
strategies and incorporate questions related to broader
implementation (e.g., facilitators and barriers). The stake-
holder interviews focus on ERIC implementation strategies
(use advisory boards and workgroups, prepare patients/con-
sumers to be active participants, and build a coalition).
Participants
Participants (n = 19) are parent advocates, multidiscip-
linary healthcare providers, members/leaders of key
pediatric oncology professional organizations, and
leaders in the pediatric healthcare industry.
Procedure
Each stakeholder will be interviewed by video conference
using a theoretically driven and empirically based semi-
structured interview guide [41]. The purpose of the
interview is to refine strategies I and II, identify add-
itional barriers or facilitators of implementation across
the patient/family, provider, and institution levels, and
ensure PAT implementation strategies address these
barriers to reduce disparities in care.
Cluster-randomized comparative effectiveness trial (aim 2)
PAT implementation will be tested using a head-to-head
randomized implementation (comparative effectiveness
of two implementation strategies) trial initiated in three
cohorts of 1 year each (2021, 2022, 2023). All 18
pediatric cancer programs invited to participate in the
trial agreed to a 2-step randomization process stratified
by size of site; sites will be randomized to one of three
cohorts and then to strategy, comparing strategy I (train-
ing) with strategy II (TIER).
Selection of sites
The following criteria were used in site selection:
1. Provide staff and tablet computer for screening. Each
site agreed to provide the staff person(s) screening
and tablets. Each site will be provided support for a
portion of the site PI’s effort and a part-time re-
search coordinator based on center size for pur-
poses of research only (the research coordinator
will not do the screening).
2. Center size. Because program size is related to the
size of the psychosocial team and related
psychosocial resources [5], we used PIPS-CSS data
to stratify by size to obtain three equal and clinically
relevant groups based on number of new pediatric
cancer patients annually—small (30–60), medium
(61–149), and large (150+). We selected 6 sites for
each of the three size categories.
3. Psychosocial staff. To assure that there are staff to
conduct screening and act on the results of
screening, selected sites are at or above the median
for the size of their psychosocial team (number [full
time equivalents] social workers + psychologists +
psychiatrists + child life specialists) [5] based on
PIPS-CSS data.
4. Diversity of population. We selected centers in
states with a high percentage of ethnic or racial
minority families and/or families with
socioeconomic disadvantage. CA, TX, FL, NY, and
NJ have large Hispanic populations [42]. AL, NC,
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and VA have the most rapidly increasing Hispanic
populations, and AL, LA, NC, and VA have the
largest percentage of African-Americans [43]. Thir-
teen out of 18 sites are in these states. Twelve out
of 18 are in states with > 20% of children living in
poverty [44]. Other sites were selected to balance
geography, race, ethnicity, and SES.
Participants
Since screening will be integrated into the clinical ser-
vices of the centers, it will be routine clinical care.
Coded EHR data with minimal protected health infor-
mation (PHI) will be collected for patients. Reflecting
the importance of staff in implementation [45], con-
sented participants include the site PI and screeners and,
in strategy II, the champion.
Procedure
All sites, regardless of randomization to strategy I or II,
will participate in a 3-h professionally prepared webinar
(develop educational materials, distribute educational
materials) at the beginning of their cohort year. The
webinar will include all information necessary to under-
stand, access, and deliver the web-based PAT. The webi-
nar will be based on our in-person training program and
curriculum [35] modified to integrate feedback from aim
1 interviews. Each site PI, all screeners, and the research
coordinator will participate. For sites randomized to
strategy II, the champion will attend. We will work with
sites to identify this team and the champion (in TIER)
“individuals who dedicate themselves to supporting,
marketing, and driving through an implementation,
overcoming indifference or resistance that the interven-
tion may encounter in an organization” [37].
Fig. 3 Study flow diagram
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After the PAT is completed online, it is scored imme-
diately, and a summary of the score and clinical con-
cerns identified is generated. Only coded data will be
transmitted to the study data core. A master list for this
data will be maintained at each respective study site and
will not be shared with the core research team. We will
provide support to sites in the technical aspects of the
implementation related to using the web-based forms
(centralize technical assistance). If we identify any pat-
tern of problems with technical aspects of implementa-
tion, we will communicate with sites promptly.
PAT implementation plan
Each site will complete an implementation plan, describ-
ing who will be screened, where results will be stored,
how results will be communicated to families and to
staff, and how results will be used (develop a formal im-
plementation blueprint). For TIER, the plan includes the
responsibilities of the champion.
Strategy I
For sites randomized to strategy I, the webinar is the im-
plementation condition. Sites will receive technology
support, as needed, throughout the implementation
period. These strategies correspond to implementation
strategies—creating a structure for implementation in-
cluding creating implementation teams and developing
an implementation plan [37].
Strategy II
Strategy II includes the webinar and technical support as
above with the addition of two evidence-based resources
that may improve implementation. The site PI and cen-
ter staff conducting screening will participate in a
monthly 1-h consultation call (provide ongoing consult-
ation, create a learning collaborative) with other TIER
sites in that cohort. The group format of this strategy is
intended to foster group problem-solving and peer sup-
port about issues in implementation. Sites will identify a
champion (identify and prepare champions) who will ad-
vocate for PAT implementation and support staff in
screening activities by serving as a resource to problem-
solve and communicate with the broader clinical staff
about screening and psychosocial risk. The champion
will likely be a clinical leader with enthusiasm and com-
mitment to universal psychosocial risk screening.
Measurement/outcomes (all sites)
The measures assess outcomes across patient/family,
provider, and institution levels (Table 1) that are clearly
operationalized and reproducible [46]. Site PIs and coor-
dinators will attend training on data collection proce-
dures, in separate sessions for the two conditions.
At the patient/family level (Hyp 2.1) the site coordin-
ator will extract EHR data and send the coded data via
REDCap to the data core. The following data for English
and Spanish versions of the PAT will be reported
monthly: new patients meeting eligibility requirements
per the PAT implementation plan; patients with docu-
mentation of PAT screening; patients receiving feedback
letter; demographic data on all eligible and all screened
(race, ethnicity, zip code, insurance).
At the provider level (Hyp 2.2), the site PI and
screeners will complete the following self-report mea-
sures (~ 15min) at baseline (T1), and 6 (T2) and 12
(T3) months via REDCap: acceptability of intervention
measure; intervention appropriateness measure and
feasibility of intervention measure [47]; measure of phys-
ician engagement in addressing racial and ethnic health
care disparities [48], satisfaction of employees in health-
care survey [49], and Maslach Burnout Inventory [50].
The outcomes at the institution level (Hyp 2.3) are as
follows: adoption, the intention of sites to use the PAT
(the ratio of sites that initiate the study); whether screen-
ing is perceived as an asset to the institution using the
PAT Implementation Questionnaire (PIQ) [35] which
will be completed by the site PI, the screeners, and the
champion at T1, T2, and T3; whether services are
matched to the needs of families based on PPPHM levels
using EHR data using the Psychosocial Services and
Medical Treatment Checklist (PSMTC) [18] at 30, 60,
and 90 days; cost using the data from the PSMTC to es-
timate the amount of psychosocial staff time and na-
tional median hourly salary data [51–53]. The Intensity
of Treatment Rating Scale (ITR-3) [54] will be com-
pleted at the 90-day post-screening data collection time
point based on diagnosis, stage, and treatment.
Fidelity
Whether the PAT was administered as intended will be
assessed using monthly EHR data. The coded data cap-
tured at Nemours will also allow us to confirm the com-
pletion of each PAT in its entirety. The coordinators will
meet monthly to problem-solve any concerns about data
collection. In the TIER condition, attendance on calls
and minutes of the monthly consultation calls will be
prepared. The champion will complete a questionnaire
at the beginning of the study year, and at 6 and 12
months to document their activities.
Dissemination toolkit (aim 3)
To broadly disseminate the PAT, a theoretically and
data-driven web-based PAT Implementation Toolkit will
be developed with the information, resources, and tools
necessary to implement the PAT. This corresponds with
the Prevention Delivery System of the ISF (develop
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educational materials, distribute educational materials,
purposely re-examine the implementation) [37].
Participants
There will be 20 purposively sampled participants from
the aim 1 stakeholders (n = 10) and from sites that im-
plemented the PAT in aim 2 (n = 10 site PIs and cham-
pions). Cognitive interviews will be conducted to
ascertain their interpretation and understanding of the
PAT Implementation Toolkit. This sample size is con-
sistent with the PROMIS methods [55] and the past ex-
perience of the research team [56].
Procedure
Subsequent to the final analysis of data from the aim 2
trial, we will refine the preliminary framework for the
PAT Implementation Toolkit website which we expect
will include the training webinar, technology support,
PAT Implementation Plan, complete information to
implement the PAT across centers of different sizes, ma-
terials specific to using the Spanish version of the PAT,
suggestions for overcoming identified barriers and
bolstering facilitators, evidence for how screening can
impact health disparities, frequently asked questions,
and guide for sites in identifying resources to guide
intervention based on PAT scores. The Toolkit will be
web-based and easily accessible.
Cognitive interviews
Qualitative, think-aloud interviews [57] will be con-
ducted by video conference using a semi-structured
interview guide. During this audio-recorded interview,
providers “walk through” the web-based PAT Implemen-
tation Toolkit to identify areas for clarification and
improvement. Interviews will be transcribed by a profes-
sional transcription service and uploaded to a qualitative
data management program (Atlas.ti ©) for formal
coding.
Dissemination
The Agency for Healthcare Research and Quality Pub-
lishing and Communications Guidelines (https://www.
ahrq.gov/research/publications/pubcomguide/index.
html) will guide dissemination. We will coordinate with
Children’s Oncology Group (COG) to assure sites have
access to the Toolkit. We will contact all sites in the
PIPS-CSS study to support their use of the Toolkit. As a
site in the National Cancer Institute Community Oncol-
ogy Research Program (NCORP), we will include a
broad network of community and minority sites.
Data analysis
Aim 1
The interviews will be electronically recorded and pro-
fessionally transcribed. All data will be stored and man-
aged on a secure drive. Data will be inductively analyzed
using Atlas.ti ©. Content analytic strategies will be used
to identify codes, categories, and themes [58, 59]. Ana-
lysis will proceed as the investigators simultaneously col-
lect information through interviews, read each interview
as an individual case, consider the topics addressed in
the interview guide, disassemble each interview through
coding with preliminary codes, define and combine
codes into categories and categories into themes, and
consider data from each category across all cases [60].
We will first independently code three interviews se-
lected to represent different stakeholders (patient/family,
providers, and institution) to define an initial set of
codes and codebook. Study coordinators will be trained
to manage and analyze qualitative data [61–63] and su-
pervised by an expert qualitative researcher. The investi-
gators will independently code five interviews. For the
remaining interviews, each transcript will be coded inde-
pendently by a two-person team that will discuss each
Table 1 Measurement





EHR (monthly) Demographics: race, ethnicity, zip code, insurance
No. eligible families, English/Spanish
No. eligible families screened, English/Spanish





Engagement in addressing health disparities
Job satisfaction
Burnout
Survey (Pre, 6-month, Post) Acceptability of intervention measure
Intervention appropriateness measure
Feasibility of intervention measure
AREA scale of physician engagement
Satisfaction employees healthcare





Cost-effectiveness: services/need and cost
Survey Site participation rate
PAT implementation questionnaire
EHR (monthly) Psychosocial Services and Medical Treatment Checklist
Intensity of Treatment Rating Scale
Kazak et al. Implementation Science           (2020) 15:60 Page 8 of 13
interview and reconcile any discrepancies until they
reach 75% agreement. After this point, interviews will be
coded independently but will be reviewed and discussed
if a discrepancy is found. The investigators will review
all the coded transcripts. As coding continues, codes will
be combined into categories. Finally, all data will be ex-
amined in each category to combine categories into
themes. The themes will be translated into content of
the PAT webinar for strategy I and enhanced strategies
included in strategy II with attention to health disparities
and barriers and facilitators at the patient/family, pro-
vider, and institution levels. The rigor of the iterative
analytic process will follow standards for qualitative re-
search [63, 64].
Aim 2
PAT implementation will be tested using a head-to-head
randomized implementation (comparative effectiveness
of two implementation strategies) trial in three cohorts
over 3 years. Randomization. Eighteen sites will be ran-
domized to one of three cohorts. Each cohort will be
further randomized to one of the two strategy condi-
tions. Randomization will stratify sites by size to
maximize internal validity and statistical power. Sites
will be randomized by a data analyst not connected with
the study using a two-step Excel = RAND() function.
The sequence will be stored in a password-protected
electronic file. Sample size. The estimated sample of
patients/families is based on the median number of new
patients each year from the PIPS-CSS database: small
(n = 60), medium (n = 92), large (n = 339) multiplied by
6 sites at each size, a total of 2946, with 1473 families
allocated to each strategy. With an anticipated Interclass
Correlation Coefficient (ICC) [65] of .005, the effective
sample size is 950 per arm, a sample size that is suffi-
cient to detect a small effect between the two strategies
given 80% power (alpha = .05, one sided). We project a
Hispanic sample of 20% of the total (n = 589). Based on
our research [8], approximately 30% of Hispanic care-
givers will be more acculturated/not literate in Spanish
at the level necessary to complete the Spanish PAT, ren-
dering a sample of 412. With an anticipated ICC of .005,
the effective sample size is 224 which is sufficient to de-
tect a medium effective between the English and Spanish
versions given 80% power (alpha = .05, one sided). At
the provider level, each of 18 sites has a PI and up to
four people screening, and for TIER sites, a champion.
Therefore the staff sample ranges from a minimum of
45 ([18 × 2] + 9) to a maximum of 99 ([18 × 5] + 9),
likely in the middle given the range of size of sites. At
the institution level, 18 sites will be randomly assigned
to one of two strategies (9 sites/group). These sample
sizes are comparable to other implementation science
studies [66].
Data cleaning and missing data
All data will be reviewed for valid values/data entry er-
rors, outliers, and extent/pattern of missing data.
Descriptive statistics will be reviewed. Consistency and
logic checks will be applied for review/cleaning. The
multiple group analysis models will provide valid esti-
mates of efficacy if the proportion of missing values is
< 10%. Analysis will be conducted at the patient/family,
provider, and institution levels. The effect of program
size and cohort will be examined and controlled if
needed.
H2.1. ANOVA will compare the effectiveness of the
two implementation strategies on penetration and
health equity. The outcomes are proportions: families
screened/families eligible, families provided feedback/
families screened, ethnic minority families screened/
ethnic minority families eligible, low SES families
screened/low SES families eligible. ICCs among the
clusters will be calculated and used to adjust for the
cluster effect [67, 68].
H2.2. Three sets of outcome variables—perception of
implementation, engagement in addressing health
disparities, and burnout/job satisfaction—will be tested.
A two group analysis using Structural Equation
Modeling (SEM) will compare the effectiveness of the
two strategies [69, 70]. To test the effect of time, we
will conduct latent growth curve analysis [71–73].
Analyses will be conducted using Mplus 5.0 [74] with
ML estimation for outcome variables that meet the
distribution assumptions, and WLSMV estimation for
variables that do not. Potential mediating effects of
favorable perception of implementation on provider job
satisfaction and burnout will be examined using
mediation models. TIER is expected to be associated
with more favorable perceptions of implementation,
less burnout, and higher job satisfaction.
H2.3. At the institution level, adoption of the PAT will
be measured by a ratio of sites that initiate
implementation/sites that agreed (H2.3a). If
substitutions are necessary, sites that are newly invited
will be added to the denominator and adoption
calculated by total acceptances/total invited. ANOVA
will be conducted to compare the effectiveness of the
two strategies. For H2.3b sustainability (PIQ
perceptions of implementation benefits and challenges),
ANOVA will be conducted to compare the
effectiveness of the two strategies on benefits and
challenges. For H2.3c, we are interested in the extent to
which psychosocial care is matched to need. A cost-
effectiveness threshold or criterion to which to com-
pare costs of screening with these two implementation
strategies has not been established, necessitating our
consideration of valued outcomes in the psychosocial
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screening literature and resources available. We will use
a data analytic approach that we used previously [18].
ANOVA will be conducted to test whether psycho-
social care is matched with levels of psychosocial risks,
resulting in a 2 (strategy) × 3 (psychosocial risks: clin-
ical, targeted, universal) design on equitable distribution
of services and costs of care. It is expected that the 3
PPPHM levels will be related to number and costs of
services provided as measured on the PSMTC, with
least at universal and most at clinical. It is expected
that TIER will result in a better match between level of
risk and services provided. Scores from the PSMTC will
be derived and mapped onto the levels of the PPPHM.
Additional analyses will be conducted to compare
English speaking and Spanish speaking families, differ-
ent ethnicity, race, and SES and insurance status on the
outcome variables for H2.3c.
Aim 3
We will summarize the data by item and then aggregate
the results across participants to reflect potential
problems with Toolkit components and to identify com-
ponents that are clear and supportive of effective imple-
mentation [56]. To ensure rigor, we will systematically
analyze and then summarize the interview data following
a formal coding scheme. Subsequently, we will develop a
cognitive interviewing outcome report, a description of
the number and type of participants and interviews com-
pleted, a description of the specific procedures used in
the interviews and the interview guide, and a written
summary of feedback on each of the components [56].
This report will be distributed to the study team who
will discuss the issues identified. Decisions will be docu-
mented in a tracking matrix [75]. Based on this feed-
back, with aim 2 data and theoretical frameworks, we
will revise and finalize the Toolkit.
Discussion
Family psychosocial screening, a Standard of Care, if im-
plemented consistently and across children’s cancer pro-
grams can reduce disparities in care by facilitating care
matched to need, and promote adaptation. The aim of
this research is to implement universal, systematic family
psychosocial risk screening with the PAT in English and
Spanish to assure that all families of children newly di-
agnosed with cancer at the participating cancer centers
are screened. Guided by the ISF for Dissemination and
Implementation [36], this study will result in the
development and broad dissemination of a PAT Imple-
mentation Toolkit for successful and sustainable imple-
mentation of universal, comprehensive, evidence-based
family psychosocial screening for all families in pediatric
oncology. As one of the few applications of implementa-
tion science in pediatric cancer, the results of this trial
will provide valuable information about what strategies
are effective in supporting comprehensive care. The
broad theory proposed by the ISF is innovative in this
field and provides a broad, forward looking approach to
the process of advancing integrated care.
This project is ambitious and has some potential chal-
lenges. If a site that agreed to participate is unavailable,
we have other eligible sites at each size to approach. We
will retain the balance of sites from states with health
disparity populations if we make substitutions. Second,
to focus on population-based implementation, we did
not consider sites with fewer than 30 new patients annu-
ally, and we selected sites with psychosocial staff at the
median or above for their size. In addition, our selection
criteria (minority population, psychosocial staff) pre-
cluded some sections of the USA, particularly less popu-
lated states with the smallest centers. Thus, we will not
be able to generalize implementation to the smallest
sites with fewer resources. However, we will distribute
the PAT Implementation Toolkit to these sites and seek
to evaluate the impact of broader dissemination of the
Toolkit across sites of different sizes and different geo-
graphic locations. Finally, for cost-effectiveness, measur-
ing the cost of psychosocial care is complicated and
largely without precedent. Involvement of healthcare
leaders in aims 1 and 3 will provide expert input in lar-
ger system level change to support family psychosocial
risk screening and psychosocial care in pediatric cancer.
The importance of evidence-based psychosocial care
for children with cancer and their families is recognized.
However, too frequently, families of children with cancer
do not receive this care, magnifying health disparities in
our increasingly diverse pediatric oncology population.
These inequities relate directly to screening for family
psychosocial risks associated with social and relational
determinants of health. Implementation of an evidence-
based, parent report screener of family psychosocial risk
across the social ecology in English and Spanish may ad-
dress these health disparities. Risk screening initiates a
process of preventive interventions across treatment.
Universal, systematic screening assures that assessments
are integrated and resources meet the needs of all chil-
dren with cancer and their families.
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